Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-22T16:09:30.693Z Has data issue: false hasContentIssue false
  • English
  • Français

Chlorpromazine and Trifluoperazine in the Treatment of Behavioural Abnormalities in the Severely Subnormal Child

Published online by Cambridge University Press:  29 January 2018

H. Hunter  and
G. M. Stephenson
H. Hunter
Affiliation:
Balderton Hospital
G. M. Stephenson
Affiliation:
Nottingham University
Get access Rights & Permissions [Opens in a new window]

Extract

A prime obstacle in the training and socialization of the severely subnormal child is behavioural abnormality; drug therapy is most widely used in its control. Until the introduction of tranquillizers, sedatives were normally used. Unfortunately these caused not only motor, but mental retardation. The advent of phenothiazines appeared to offer a solution to this problem.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 109 , Issue 460 , May 1963 , pp. 411 - 417
Copyright
Copyright © Royal College of Psychiatrists, 1963

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Adamson, W. C., et al. (1958). “Use of tranquilizers for mentally deficient patients”, Amer. J. Dis. Child., 96, 59.Google Scholar
2. Blair, H. V., and Herold, W. (19—). “Efficacy of chlorpromazine in hyperactive mentally retarded children”, Arch. Neurol. Psychiat. (Chicago), 74, 363.Google Scholar
3. Craft, M. (1957). “Tranquilizers in mental deficiency: Chlorpromazine”, J. Ment. Def. Res., 1, 91–95.Google Scholar
4. Lawlis, M. G. (1958). “A note on trifluoperazine in the management of hyperactive mentally retarded children”, Trifluoperazine: Clinical and Pharmacological Aspects. Philadelphia: Lea & Febiger, p. 180.Google Scholar
5. Le Vann, W. L. J. (1959). “Trifluoperazine dihydrochloride: an effective tranquilizing agent for behavioural abnormalities in defective children”, Canad. med. Ass. J., 80, 123.Google Scholar
6. Lowther, C. H. (1960). “Clinical experience with trifluoperazine in low-grade mental defectives, ibid., 82, 1158.Google ScholarPubMed
7. Linford Rees, (1961). “Psychotropic drugs”, a Special Article in The Medical Annual. Bristol: John Wright & Sons Ltd.Google Scholar
8. Schiller, , Harold, (1959). “Reserpine, chlorpromazine and the mentally retarded”, Psychiat. Quart., 33, 613.CrossRefGoogle Scholar
9. Stott, D. H., and Sykes, E. G. (1956). The Bristol Social Adjustment Guides. Univ. of London Press.Google Scholar
10. Vasconcellos, J. (1960). “Clinical evaluation of trifluoperazine in maximum-security braindamaged patients with severe behavioural disorders”, J. Clin. Exp. Psychopath., 21 (1), 25–30.Google Scholar
11. Wilcoxon, F. (1949). Some Rapid Approximate Statistical Procedures. Stamford, Conn.: Cyanamid Co.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.